|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 14/33 | |
| C12N 1/20 | |||
| C12P 21/02 | |||
| A61K 38/16 |
| (11) | Patento numeris | 3252070 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17180720.9 |
| Europos patento paraiškos padavimo data | 2010-07-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-12-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-10-02 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 502181 | 2009-07-13 | US |
| (72) |
TON, Jennifer L., US
PATEL, Hemant A., US
BATES, Ronald C., US
AHMAD, Wajdie M., US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | PROCESS AND SYSTEM FOR OBTAINING BOTULINUM NEUROTOXIN |
| PROCESS AND SYSTEM FOR OBTAINING BOTULINUM NEUROTOXIN |